Return to search

Galen Sells JDS Pharma

Galen Partners and AIG Healthcare Partners has sold JDS Pharmaceuticals, a specialty pharmaceutical company, to Noven Pharmaceuticals for approximately $125 million cash at closing plus the assumption of approximately $10 million in net liabilities. www.noven.com